Table 1.
Characteristics of 774 adults hospitalized with COVID-19 in Atlanta, Georgia
| Characteristic | Value |
|---|---|
| Age, median (IQR), yr | 62 (50–73) |
| Female sex, n (%) | 385 (49.7) |
| Hispanic ethnicity, n (%) | 48 (6.2) |
| Body mass index, median (IQR), kg/m2 (n = 759) | 29 (24–34) |
| Elixhauser comorbidity index, median (IQR) (n = 773) | 5 (3–8) |
| Race, n (%) | |
| Black | 514 (66.4) |
| White | 156 (20.2) |
| Unknown | 86 (11.1) |
| Asian | 17 (2.2) |
| American Indian/Alaska Native | 1 (0.1) |
| Comorbidities, n (%) | |
| Hypertension | 584 (75.5) |
| Diabetes mellitus | 354 (45.7) |
| Chronic kidney disease | 242 (31.2) |
| Cancer | 130 (16.8) |
| Liver disease | 93 (12.0) |
| Immunocompromised | 56 (7.2) |
| Laboratory results, median (IQR) | |
| WBC, ×103/µl | 7.7 (5.9–10.8) |
| Lymphocyte count, ×103/µl (n = 673) | 1.2 (0.9–1.7) |
| Hemoglobin, g/dl | 12.8 (11.5–14.1) |
| Platelets, ×103/µl | 247 (189–322) |
| Creatinine, mg/dl (n = 773) | 1.2 (0.9–1.9) |
| AST, U/L (n = 760) | 38 (25–57) |
| ALT, U/L (n = 760) | 25 (16–42) |
| Total bilirubin, mg/dl (n = 760) | 0.6 (0.4–0.8) |
| D-dimer, ng/dl (n = 579) | 1360 (755–3663) |
| CRP, mg/L (n = 590) | 131 (70–206) |
| ESR, mm/h (n = 78) | 58 (36–85) |
| LDH, U/L (n = 569) | 338 (259–452) |
| Ferritin, ng/ml (n = 385) | 433 (184–1019) |
| Troponin-I, ng/ml (n = 596) | 0.03 (0.03–0.08) |
| IL-6, pg/ml (n = 166) | 9 (5–20) |
| Medications administered, n (%) | |
| Dexamethasone | 54 (7.0) |
| Any steroid | 146 (18.9) |
| Outcomes | |
| Intensive care unit admission, n (%) | 335 (43.2) |
| Mechanical ventilation, n (%) | 238 (30.7) |
| Duration of mechanical ventilation, median (IQR), d | 10 (5–16) |
| Died, n (%) | 120 (15.5) |
Definition of abbreviations: ALT = alanine aminotransferase; AST = aspartate aminotransferase; COVID-19 = coronavirus disease; CRP = C-reactive protein; ESR = erythrocyte sedimentation rate; IL-6 = interleukin-6; IQR = interquartile range; LDH = lactate dehydrogenase; WBC = white blood cells.